Literature DB >> 30721454

Remission of light chain proximal tubulopathy in IgG λ-type multiple myeloma by lenalidomide and dexamethasone therapy.

Shinya Kawamoto1, Yuji Hidaka2, Yu Kaneko2, Hideo Misawa2, Katsuhiro Nagahori2, Atsunori Yoshino2, Takamitsu Okamura3, Shinichi Ban4, Yoshihiko Ueda4, Tetsuro Takeda2.   

Abstract

Light chain proximal tubulopathy is a rare manifestation of monoclonal gammopathy. A 73-year-old Japanese woman was noted to have urinary protein and hypertension on health examination and visited the regional clinic. She was noted to have IgG λ M protein and suspected of multiple myeloma. She was referred to us with massive proteinuria (7.5 g/g creatinine) and Bence Jones proteinuria without renal dysfunction. A renal biopsy revealed no glomerular abnormalities, but a tubular cast was observed partially in tubules without tubular atrophy or a crystalline structure. Direct Fast Scarlet staining was absent both in glomerulus and vascular wall. Immunofluorescence revealed λ light chain (LC) staining in the proximal tubules. Electron microscopy revealed nonspecific findings including increased lysosomes with irregular contours and mottled appearance. A bone marrow biopsy revealed plasma cell proliferation (35%) and multiple myeloma immunoglobulin G λ type. She showed progressive anemia and decrease of eGFR with elevated level of urinary β-2 microglobulin. She was treated with lenalidomide + dexamethasone (Ld). With Ld therapy, she achieved hematologic and nephrologic remission reducing the free LC, λ/κ ratio, urinary protein level, and urinary β-2 microglobulin level.

Entities:  

Keywords:  IgG lambda M protein; Lenalidomide; Light chain proximal tubulopathy; Multiple myeloma

Mesh:

Substances:

Year:  2019        PMID: 30721454      PMCID: PMC6620366          DOI: 10.1007/s13730-019-00382-8

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  17 in total

1.  Light chain proximal tubulopathy.

Authors:  Leal C Herlitz; Joseph Roglieri; Regina Resta; Govind Bhagat; Glen S Markowitz
Journal:  Kidney Int       Date:  2009-01-21       Impact factor: 10.612

2.  Autocrine and Paracrine Interactions between Multiple Myeloma Cells and Bone Marrow Stromal Cells by Growth Arrest-specific Gene 6 Cross-talk with Interleukin-6.

Authors:  Miki Furukawa; Hiroshi Ohkawara; Kazuei Ogawa; Kazuhiko Ikeda; Koki Ueda; Akiko Shichishima-Nakamura; Emi Ito; Jun-Ichi Imai; Yuka Yanagisawa; Reiko Honma; Shinya Watanabe; Satoshi Waguri; Takayuki Ikezoe; Yasuchika Takeishi
Journal:  J Biol Chem       Date:  2017-01-31       Impact factor: 5.157

Review 3.  Crystalline nephropathies.

Authors:  Leal C Herlitz; Vivette D D'Agati; Glen S Markowitz
Journal:  Arch Pathol Lab Med       Date:  2012-07       Impact factor: 5.534

4.  Immunofluorescence on pronase-digested paraffin sections: a valuable salvage technique for renal biopsies.

Authors:  S H Nasr; S J Galgano; G S Markowitz; M B Stokes; V D D'Agati
Journal:  Kidney Int       Date:  2006-10-25       Impact factor: 10.612

5.  The morphologic spectrum and clinical significance of light chain proximal tubulopathy with and without crystal formation.

Authors:  Christopher P Larsen; Jane M Bell; Alexis A Harris; Nidia C Messias; Yihan H Wang; Patrick D Walker
Journal:  Mod Pathol       Date:  2011-06-24       Impact factor: 7.842

6.  Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma.

Authors:  Meletios Dimopoulos; Andrew Spencer; Michael Attal; H Miles Prince; Jean-Luc Harousseau; Anna Dmoszynska; Jesus San Miguel; Andrzej Hellmann; Thierry Facon; Robin Foà; Alessandro Corso; Zvenyslava Masliak; Marta Olesnyckyj; Zhinuan Yu; John Patin; Jerome B Zeldis; Robert D Knight
Journal:  N Engl J Med       Date:  2007-11-22       Impact factor: 91.245

7.  Review of 1027 patients with newly diagnosed multiple myeloma.

Authors:  Robert A Kyle; Morie A Gertz; Thomas E Witzig; John A Lust; Martha Q Lacy; Angela Dispenzieri; Rafael Fonseca; S Vincent Rajkumar; Janice R Offord; Dirk R Larson; Matthew E Plevak; Terry M Therneau; Philip R Greipp
Journal:  Mayo Clin Proc       Date:  2003-01       Impact factor: 7.616

8.  Lenalidomide after stem-cell transplantation for multiple myeloma.

Authors:  Philip L McCarthy; Kouros Owzar; Craig C Hofmeister; David D Hurd; Hani Hassoun; Paul G Richardson; Sergio Giralt; Edward A Stadtmauer; Daniel J Weisdorf; Ravi Vij; Jan S Moreb; Natalie Scott Callander; Koen Van Besien; Teresa Gentile; Luis Isola; Richard T Maziarz; Don A Gabriel; Asad Bashey; Heather Landau; Thomas Martin; Muzaffar H Qazilbash; Denise Levitan; Brian McClune; Robert Schlossman; Vera Hars; John Postiglione; Chen Jiang; Elizabeth Bennett; Susan Barry; Linda Bressler; Michael Kelly; Michele Seiler; Cara Rosenbaum; Parameswaran Hari; Marcelo C Pasquini; Mary M Horowitz; Thomas C Shea; Steven M Devine; Kenneth C Anderson; Charles Linker
Journal:  N Engl J Med       Date:  2012-05-10       Impact factor: 91.245

9.  Lambda Light Chain Crystalline Cast Nephropathy and Proximal Tubulopathy.

Authors:  Alexander J Gallan; Mazdak A Khalighi
Journal:  Kidney Int Rep       Date:  2016-08-12

10.  Lenalidomide as a Beneficial Treatment Option for Renal Impairment Caused by Light Chain Deposition Disease.

Authors:  Satoshi Kimura; Hiroshi Ohkawara; Kazuei Ogawa; Mizuko Tanaka; Takahiro Sano; Kayo Harada-Shirado; Hiroshi Takahashi; Koki Ueda; Akiko Shichishima-Nakamura; Hayato Matsumoto; Kazuhiko Ikeda; Junichiro James Kazama; Yuko Hashimoto; Takayuki Ikezoe
Journal:  Intern Med       Date:  2018-08-10       Impact factor: 1.271

View more
  1 in total

1.  Clinicopathological characteristics of light chain proximal tubulopathy in Korean patients and the diagnostic usefulness of immunohistochemical staining for immunoglobulin light chain.

Authors:  Minsun Jung; Youngeun Lee; Hajeong Lee; Kyung Chul Moon
Journal:  BMC Nephrol       Date:  2020-04-23       Impact factor: 2.388

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.